Press release
Global Biosimilars Market Size Growing at 24.7% CAGR, Set to Reach USD 143.6 Bn By 2031, Exclusive Report
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/162
Key Takeaways:
The biosimilars market has been experiencing significant growth in recent years. Biosimilars are highly similar versions of approved biologic drugs, offering comparable safety, efficacy, and quality to the reference products.
The primary driving factors behind the biosimilars market growth include the expiry of patents for several biologic drugs, increasing healthcare costs, and the need for affordable treatment options.
Biosimilars provide an opportunity for cost savings and improved access to essential therapies. They can potentially reduce healthcare expenditures by offering lower-priced alternatives to expensive biologics.
Regulatory frameworks have been established in various countries to ensure the safety and efficacy of biosimilars. These frameworks include stringent comparability studies and clinical trials to demonstrate biosimilarity to the reference product.
Market Drivers:
Patent Expirations: The expiration of patents for reference biologic drugs creates opportunities for biosimilar manufacturers to enter the market and offer more affordable alternatives.
Cost Savings: Biosimilars provide cost savings compared to their reference biologic drugs. As healthcare costs continue to rise, payers and healthcare providers are increasingly seeking cost-effective treatment options, driving the demand for biosimilars.
Increasing Demand for Biologics: Biologic drugs have revolutionized the treatment of various diseases, including cancer, autoimmune disorders, and chronic conditions. The increasing demand for these therapies creates a significant market opportunity for biosimilars.
Request for Customization -
https://www.alliedmarketresearch.com/request-for-customization/162
Competitive Landscape:
Pfizer Inc.
Novartis AG (Sandoz)
Amgen Inc.
Biocon Ltd.
Celltrion Inc.
Samsung Bioepis Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Fresenius Kabi AG
Dr. Reddy's Laboratories Ltd.
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/162
VALUE PROPOSITIONS RELATED TO THE REPORT:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Browse more latest healthcare reports:
Sperm Bank Market https://www.alliedmarketresearch.com/sperm-bank-market-A10372
Cancer Diagnostics Market https://www.alliedmarketresearch.com/cancer-diagnostics-market-A11336
Psoriatic Arthritis Treatment Market https://www.alliedmarketresearch.com/psoriatic-arthritis-treatment-market-A05951
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Biosimilars Market Size Growing at 24.7% CAGR, Set to Reach USD 143.6 Bn By 2031, Exclusive Report here
News-ID: 3085158 • Views: …
More Releases from Allied Market Research
Advanced Protective Gear and Armor Market Worth $26.54 billion by 2030, Supporte …
Advanced protective gear and armor market size was pegged at $12.13 billion in 2020, and is expected to reach $26.54 billion by 2030, growing at a CAGR of 7.4% from 2021 to 2030.
Rise in terrorist activities and warfare situations across the world and strict laws & regulations about work environment safety have boosted the growth of the global advanced protective gear and armor market. However, low safety compliance in the…
North America and Asia-Pacific Food Waste Prevention Market Projected Expansion …
According to a new report published by Allied Market Research, titled, "North America and Asia-Pacific food waste prevention market" The North America and Asia-Pacific food waste prevention market size was valued at $11.0 billion in 2022, and is projected to reach $21.6 billion by 2032, growing at a CAGR of 7.2% from 2023 to 2032.
Rise in awareness of food waste as a large and urgent problem, especially in developing countries,…
Horse Betting Market's CAGR Surge: A USD Billion Dollar Growth Story 2022 - 2032
Horse betting, one of the oldest forms of bet, has evolved dramatically over the centuries. From its origins in ancient civilizations to the high-tech, data-driven industry it is today, the horse betting market has adapted to cultural, technological, and economic shifts. This article explores the current landscape of the horse betting market, its challenges, opportunities, and the factors driving its growth.
The horse betting market was valued at $44.3 billion in…
Password Management Market Growing at a 20.7% CAGR Reach USD 15.2 Billion by 203 …
Allied Market Research published a new report, titled, " Password Management Market Growing at a 20.7% CAGR Reach USD 15.2 Billion by 2032 ." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and…
More Releases for Biosimilars
Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes…
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Biosimilars Market Size During the Forecast Period?
The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,…
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth?
The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
